Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sten Fredrikson

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
British Journal of Clinical Pharmacology|August 16, 2003
Interferon-beta treatment in patients with multiple sclerosis does not alter CYP2C19 or CYP2D6 activityKarin Hellman, Ewa Roos, Anna Osterlund, et al.
Scandinavian Journal of Public Health|April 4, 2013
Differences between users and non-users of complementary and alternative medicine among people with multiple sclerosis in Denmark: a comparison of descriptive characteristicsLasse Skovgaard, Peter Halkier Nicolajsen, Elena Pedersen, et al.
Health and Quality of Life Outcomes|November 17, 2010
Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre studyPeter J Jongen, Dirk Lehnick, Evert Sanders, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 23, 2006
Progression of non-age-related callosal brain atrophy in multiple sclerosis: a 9-year longitudinal MRI study representing four decades of disease developmentJuha Martola, Leszek Stawiarz, Sten Fredrikson, et al.
Journal of the Neurological Sciences|July 31, 2013
A 10-year follow-up of a population-based study of people with multiple sclerosis in Stockholm, Sweden: changes in disability and the value of different factors in predicting disability and mortalityCharlotte Chruzander, Sverker Johansson, Kristina Gottberg, et al.
Disability and Rehabilitation|January 12, 2016
A single-group pilot feasibility study of cognitive behavioural therapy in people with multiple sclerosis with depressive symptomsCharlotte Chruzander, Kristina Gottberg, Charlotte Ytterberg, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|March 20, 2015
MRI-Defined Corpus Callosal Atrophy in Multiple Sclerosis: A Comparison of Volumetric Measurements, Corpus Callosum Area and IndexTobias Granberg, Gösta Bergendal, Sara Shams, et al.
Movement Disorders Clinical Practice|January 11, 2021
Associations Between Fluctuations in Daytime Sleepiness and Motor and Non-Motor Symptoms in Parkinson's DiseaseArja Höglund, Peter Hagell, Jan-Erik Broman, et al.
Seizure|February 17, 2020
Epilepsy in immigrants and Swedish-born: A cohort study of all adults 18 years of age and older in SwedenPer Wändell, Sten Fredrikson, Axel C Carlsson, et al.
Plos One|July 6, 2019
RebiQoL: A randomized trial of telemedicine patient support program for health-related quality of life and adherence in people with MS treated with RebifAnne-Marie Landtblom, Dimitri Guala, Claes Martin, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
British Journal of Clinical Pharmacology|August 16, 2003
Interferon-beta treatment in patients with multiple sclerosis does not alter CYP2C19 or CYP2D6 activityKarin Hellman, Ewa Roos, Anna Osterlund, et al.
Scandinavian Journal of Public Health|April 4, 2013
Differences between users and non-users of complementary and alternative medicine among people with multiple sclerosis in Denmark: a comparison of descriptive characteristicsLasse Skovgaard, Peter Halkier Nicolajsen, Elena Pedersen, et al.
Health and Quality of Life Outcomes|November 17, 2010
Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre studyPeter J Jongen, Dirk Lehnick, Evert Sanders, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 23, 2006
Progression of non-age-related callosal brain atrophy in multiple sclerosis: a 9-year longitudinal MRI study representing four decades of disease developmentJuha Martola, Leszek Stawiarz, Sten Fredrikson, et al.
Journal of the Neurological Sciences|July 31, 2013
A 10-year follow-up of a population-based study of people with multiple sclerosis in Stockholm, Sweden: changes in disability and the value of different factors in predicting disability and mortalityCharlotte Chruzander, Sverker Johansson, Kristina Gottberg, et al.
Disability and Rehabilitation|January 12, 2016
A single-group pilot feasibility study of cognitive behavioural therapy in people with multiple sclerosis with depressive symptomsCharlotte Chruzander, Kristina Gottberg, Charlotte Ytterberg, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|March 20, 2015
MRI-Defined Corpus Callosal Atrophy in Multiple Sclerosis: A Comparison of Volumetric Measurements, Corpus Callosum Area and IndexTobias Granberg, Gösta Bergendal, Sara Shams, et al.
Movement Disorders Clinical Practice|January 11, 2021
Associations Between Fluctuations in Daytime Sleepiness and Motor and Non-Motor Symptoms in Parkinson's DiseaseArja Höglund, Peter Hagell, Jan-Erik Broman, et al.
Seizure|February 17, 2020
Epilepsy in immigrants and Swedish-born: A cohort study of all adults 18 years of age and older in SwedenPer Wändell, Sten Fredrikson, Axel C Carlsson, et al.
Plos One|July 6, 2019
RebiQoL: A randomized trial of telemedicine patient support program for health-related quality of life and adherence in people with MS treated with RebifAnne-Marie Landtblom, Dimitri Guala, Claes Martin, et al.
Pageof 7